ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
TVTX
#1492
Travere Therapeutics, Inc. Common Stock
29.790
0
+3.83%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+3.83%
月次変化
-0.37%
6か月変化
+3.55%
1年の変化
+3.55%
以前の終値
28.690
0
Open
29.790
0
Bid
Ask
Low
29.790
0
High
29.790
0
ボリューム
138
マーケット
株
ヘルスケア
TVTX
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
60.24 M
63.21 M
64.74 M
76.1 M
88.74 M
92.24 M
—
Valuation ratios
Enterprise value
1.56 B
1.8 B
1.28 B
669.33 M
1.49 B
3.43 B
8.23 B
Price to earnings ratio
—
-10.31
-4.73
-6.37
-4.27
-131.76
-168.49
Price to sales ratio
—
8.16
6.21
4.89
5.89
6.95
20.97
Price to cash flow ratio
—
125.55
7.07
2.54
5.79
90.22
142.12
Price to book ratio
—
6.15
30.74
3.54
23.26
29.69
58.86
Enterprise value to EBITDA ratio
-21.23
-13.03
-60.29
-1.73
-5.76
-55.99
-84.91
Profitability ratios
Return on assets %
0.28
0.23
0.41
0.14
0.54
0.04
0.06
Return on equity %
0.8
0.6
6.5
0.55
5.44
0.22
1.52
Return on invested capital %
266.12
269.48
449.73
578.2
346.46
76.72
53.95
Gross margin %
96.91
97.02
96.42
92.12
96.68
97.89
390.02
Operating margin %
88.83
71.11
125.73
267.24
138.88
12.8
64.95
EBITDA margin %
-36.98
-60.59
-9.98
-265.69
-110.65
-12.49
-103.82
Net margin %
85.43
79.16
131.35
76.7
137.9
5.21
35.43
Liquidity ratios
Quick ratio
4.35
4.64
3.37
3.41
2.04
2.51
8.63
Current ratio
4.43
4.7
3.42
3.47
2.08
2.74
9.54
Inventory turnover
0.89
0.91
1.07
1.4
0.99
0.49
0.36
Asset turnover
0.33
0.33
0.29
0.2
0.34
0.82
0.88
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.35
0.29
0.56
0.48
0.52
0.52
2.22
Long term debt to total equity ratio
1.02
0.75
8.76
1.88
5.25
2.71
25.91
Per share metrics
Operating cash flow per share
—
0.25
2.92
3.77
3.01
0.42
0.43
EBIT per share
—
-2.75
-0.85
-5.71
-3.82
-1.37
-1.84
EBITDA per share
—
-2.3
-0.33
-5.2
-3.27
-0.69
-1.16
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
7.15
5.45
4.13
0.74
2.67
7.03
Net current asset value per share
—
9.74
7.63
8.3
5.28
4.9
17.58
Tangible book value per share
—
2.55
-1.62
1.29
-0.58
0.01
-2.04
Working capital per share
—
7.67
5.4
5.91
2.74
3.11
10.08
Book value per share
—
5.05
0.67
2.7
0.75
1.29
2.85
ニュース
リガンド第4四半期2025年決算:48%のロイヤリティ成長が利益予想超えを牽引
Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX)
Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates
Travere Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-02-19
Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss
【決算速報】Travere Therapeutics、売上高は予想を下回り、利益は予想を上回る結果に
Travere Therapeutics earnings beat by $0.41, revenue fell short of estimates
FSGSの承認遅延でトラベラ・セラピューティクスが決算発表を控える
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?
Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy?